Phathom Pharmaceuticals Stock Investor Sentiment
| PHAT Stock | USD 5.99 0.35 5.52% |
Slightly above 65% of Phathom Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Phathom Pharmaceuticals stock suggests that many investors are alarmed at this time. Phathom Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Phathom Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Phathom |
Phathom Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Phathom Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Phathom Pharmaceuticals that are available to investors today. That information is available publicly through Phathom media outlets and privately through word of mouth or via Phathom internal channels. However, regardless of the origin, that massive amount of Phathom data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Phathom Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Phathom Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Phathom Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Phathom Pharmaceuticals alpha.
Phathom Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Phathom Pharmaceuticals, Inc. Q3 2024 Earnings Call Transcript | 11/11/2024 |
2 | Phathom Pharmaceuticals Stock Price Up 9.4 percent Time to Buy | 11/21/2024 |
3 | Down -54.05 percent in 4 Weeks, Heres Why Phathom Pharmaceuticals Looks Ripe for a Turnaround | 12/06/2024 |
4 | Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking | 12/11/2024 |
5 | Top Biotech Short Squeeze Stocks | 12/12/2024 |
6 | Phathom Pharmaceuticals Buy Rating Reiterated at HC Wainwright | 12/13/2024 |
7 | Frank Karbe Increases Stake in Phathom Pharmaceuticals Inc | 12/16/2024 |
8 | Disposition of 1291 shares by Henderson Molly of Phathom Pharmaceuticals at 8.0 subject to Rule 16b-3 | 12/19/2024 |
9 | Insider Selling Phathom Pharmaceuticals, Inc. CFO Sells 1,291 Shares of Stock - MarketBeat | 12/20/2024 |
10 | Disposition of 19109 shares by Terrie Curran of Phathom Pharmaceuticals at 6.5877 subject to Rule 16b-3 | 01/21/2025 |
11 | Further weakness as Phathom Pharmaceuticals drops 12 percent this week, taking five-year losses to 81 percent - Simply Wall St | 01/31/2025 |
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.